KTN's online platform helps you to make the connections you need
The Knowledge Transfer Network (KTN) has refreshed its online platform to intelligently connect you to relevant events, funding, thought pieces and specialist staff to help your business innovate and grow.
You can discover content using your area of interest, from Chemistry to transport; from space to health – all major UK economic sectors are covered. Once you have selected your interests, using our intelligent tagging system, we will then display rich and relevant content related to your area, often from surprising sources.
An example might be new satellite technology from the space sector that is applicable in the agri-food sector. KTN-UK.co.uk will help you form these unusual and valuable connections.
All content on the platform has been carefully curated by our team of innovation specialists – not by an automated algorithm – so you can be confident that KTN is connecting you to the most relevant cutting-edge information.
The move also marks a closer alignment with our main funder, Innovate UK , with the website branding making a clear visual link. Knowledge Transfer Network is Innovate UK's innovation network partner, and also works with other funders to provide innovation networking services and fulfil our mission to drive UK growth.
We link new ideas and opportunities with expertise, markets and finance through our network of businesses, universities, funders and investors. From agri-food to autonomous systems and from energy to design, KTN combines expertise in all sectors with the ability to cross boundaries. Connecting with KTN can lead to potential partners, horizon-expanding events and innovation insights relevant to your needs.
Visit our people pages to connect directly with expertise in your sector.
Visit the KTN refreshed online platfom here
Ingenza celebrates EU H2020 SME Instrument success
Ingenza is pleased to announce it has successfully applied for EU H2020 SME Instrument funding of €50,000 for Phase 1 of its innovative SYNBIOMAN project, allowing the company to forge ahead with the development of this novel synthetic biology-driven biomanufacturing platform. Successful completion of the Phase 1 study could open the door to additional funding for Phase 2, valued at €2.5 million.
SYNBIOMAN will build on Ingenza’s proprietary industrial synthetic and systems biology tools, helping small and medium-sized biotechnology enterprises to close the gap from lab to market by developing GMP biomanufacturing capabilities that target the production of therapeutic proteins. Frequently, these drug candidates are sourced from low yielding organisms, have highly complex structures, or are very toxic. As a result, they can be challenging to manufacture, preventing the development of new therapies for currently unmet clinical needs. Dr David McElroy, Chief Business Officer at Ingenza, said: “We are delighted to have secured EU H2020 SME Instrument support for this project. The Horizon 2020 programme receives thousands of funding applications each year, and fewer than five per cent of applicants are successful. It is a real achievement for our scientific research to be recognised in this way.”
Ingenza is a worldwide leaders in the application of industrial biotechnology and synthetic biology, providing efficient scalable bioprocesses to manufacture chemicals, biologics, pharmaceuticals and biofuels, from sustainable sources. Its scientific and commercial activities are led by a management team with over 25 years’ experience in applied bioscience and the development and commercialisation of bio-based products. In addition to engaging in strategic partnerships to tailor its bioprocess services for clients, the company also licenses its proprietary bioprocess technologies.